                         SEQUENCE LISTING

<110>  INSERM
 
<120>  ANTIBODIES FOR THE TREATMENT AND PREVENTION OF THROMBOSIS

<130>  BIO 11249 DENIS/MC

<160>  8     

<170>  PatentIn version 3.3

<210>  1
<211>  122
<212>  PRT
<213>  Artificial

<220>
<223>  VH

<400>  1

Gln Val Pro Leu Gln Gln Pro Gly Ala Glu Leu Val Arg Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Leu Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Ser Tyr 
            20                  25                  30          


Trp Ile Asn Trp Val Lys Gln Arg Pro Gly Gln Gly Leu Glu Trp Ile 
        35                  40                  45              


Gly Asn Ile Tyr Pro Ser Asp Ser Ser Thr Asn Tyr Asn Gln Lys Phe 
    50                  55                  60                  


Lys Asp Lys Ala Thr Leu Thr Val Asp Lys Ser Ser Ser Thr Ala Tyr 
65                  70                  75                  80  


Met Gln Leu Ser Ser Pro Thr Ser Glu Asp Ser Ala Val Tyr Tyr Cys 
                85                  90                  95      


Thr Arg Arg Gly Tyr Tyr Gly Asn Arg Tyr Asp Ala Met Asp Tyr Trp 
            100                 105                 110         


Gly Gln Gly Thr Ser Val Thr Val Ser Ser 
        115                 120         


<210>  2
<211>  10
<212>  PRT
<213>  Artificial

<220>
<223>  H-CDR1

<400>  2

Gly Tyr Thr Phe Thr Ser Tyr Trp Ile Asn 
1               5                   10  


<210>  3
<211>  17
<212>  PRT
<213>  Artificial

<220>
<223>  H-CDR2

<400>  3

Asn Ile Tyr Pro Ser Asp Ser Ser Thr Asn Tyr Asn Gln Lys Phe Lys 
1               5                   10                  15      


Asp 
    


<210>  4
<211>  13
<212>  PRT
<213>  Artificial

<220>
<223>  H-CDR3

<400>  4

Arg Gly Tyr Tyr Gly Asn Arg Tyr Asp Ala Met Asp Tyr 
1               5                   10              


<210>  5
<211>  107
<212>  PRT
<213>  Artificial

<220>
<223>  VL

<400>  5

Asn Ile Val Met Thr Gln Ser Pro Lys Ser Met Ser Met Ser Ala Gly 
1               5                   10                  15      


Glu Arg Val Thr Leu Ser Cys Lys Ala Ser Glu Asn Val Phe Thr Tyr 
            20                  25                  30          


Val Ser Trp Tyr Gln Gln Lys Pro Asp Gln Ser Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Gly Ala Ser Asn Arg Tyr Thr Gly Val Pro Asp Arg Phe Thr Gly 
    50                  55                  60                  


Ser Gly Ser Ala Thr Asp Phe Thr Leu Thr Ile Ser Ser Val Gln Ala 
65                  70                  75                  80  


Glu Asp Leu Ala Asp Tyr His Cys Gly Gln Ser Tyr Asn Tyr Pro Tyr 
                85                  90                  95      


Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  6
<211>  11
<212>  PRT
<213>  Artificial

<220>
<223>  L-CDR1

<400>  6

Lys Ala Ser Glu Asn Val Phe Thr Tyr Val Ser 
1               5                   10      


<210>  7
<211>  7
<212>  PRT
<213>  Artificial

<220>
<223>  L-CDR2

<400>  7

Gly Ala Ser Asn Arg Tyr Thr 
1               5           


<210>  8
<211>  9
<212>  PRT
<213>  Artificial

<220>
<223>  L-CDR3

<400>  8

Gly Gln Ser Tyr Asn Tyr Pro Tyr Thr 
1               5                   


